Emergent BioSolutions EBS
NYSE EBS
$6.22 +0.02 (+0.32%)
As of: Oct 22, 2026 · 3:59 PM EDT

Emergent BioSolutions (EBS) Short-term Investments (2010 - 2011)

Updated

Emergent BioSolutions' Short-term Investments came in at $1.97 million for Q4 2011, down 3.1% from $2.03 million a year earlier and down 43.8% from the prior quarter.

Analysis

Emergent BioSolutions (EBS) Short-term Investments (2010 - 2011) Analysis & Trends

Going back to Q4 2010, Emergent BioSolutions' Short-term Investments data covers 4 quarters.

  • Going back by year, Short-term Investments was $2.03 million in FY2010.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 Emergent BioSolutions 319.92 Mn -430.98 Mn 137.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2011 1.97 Mn
Sep 30, 2011 3.50 Mn
Jun 30, 2011 5.05 Mn
Dec 31, 2010 2.03 Mn
API Access

Emergent BioSolutions Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=EBS&period=max&api_key=YOUR_API_KEY